Serum creatinine and the search for new biomarkers of acute kidney injury (AKI): The story continues

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 9, 2012, Pages 1495-1499

  Bolignano, Davide ^a  

^a BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ACUTE KIDNEY FAILURE; CARDIOPULMONARY BYPASS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE COURSE; GLOMERULUS FILTRATION RATE; HUMAN; INTENSIVE CARE UNIT; ISCHEMIA; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY INJURY; LEUKOCYTOSIS; META ANALYSIS (TOPIC); MORTALITY; MULTIPLE TRAUMA; MULTIVARIATE ANALYSIS; NEPHROTOXICITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SEPSIS; SYSTEMATIC REVIEW (TOPIC);

EID: 84867834968     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2012-0099     Document Type: Review

References (39)

1. Joannidis M, Metnitz PG. Epidemiology and natural history of acute renal failure in the ICU. Crit Care Clin 2005;21:239-49.
2. Wald R, Quinn R, Luo J, Li P, Scales D, Mamdani M, et al. Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. J Am Med Assoc 2009;302:1179-85.
3. Bell M. Acute kidney injury: new concepts, renal recovery. Nephron Clin Pract 2008;109:c224-8.
4. Hoste EA, Schurgers M. Epidemiology of acute kidney injury: how big is the problem ? Crit Care Med 2008;36(Suppl 4):S146-51.
5. Soni SS, Pophale R, Ronco C. New biomarkers for acute renal injury. Clin Chem Lab Med 2011;49:1257-63.
6. Cruz DN, Bagshaw SM, Ronco C, Ricci Z. Acute kidney injury: classification and staging. Contrib Nephrol 2010;164:24-32.
7. Ricci Z, Cruz DN, Ronco C. Classification and staging of acute kidney injury: beyond the RIFLE and AKIN criteria. Nat Rev Nephrol 2011;7:201-8.
8. Delanghe JR, Cobbaert C, Harmoinen A, Jansen R, Laitinen P, Panteghini M. Focusing on the clinical impact of standardization of creatinine measurements: a report by the EFCC Working Group on Creatinine Standardization. Clin Chem Lab Med 2011;49:977-82.
9. ® Jaffe creatinine method. Clin Chem Lab Med 2011;49:1987-99.
10. Milić R, Banfi G, Del Fabbro M, Dopsaj M. Serum creatinine concentrations in male and female elite swimmers. Correlation with body mass index and evaluation of estimated glomerular filtration rate. Clin Chem Lab Med 2011;49:285-9.
11. Macedo E, Bouchard J, Soroko SH, Chertow GM, Himmelfarb J, Ikizler TA, et al., Program to Improve Care in Acute Renal Disease Study. Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients. Crit Care 2010;14:R82.
12. Coca SG, Yalavarthy R, Concato J, Parikh CR. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int 2008;73:1008-16.
13. Bakker A, Syperda H. Neutrophil gelatinase-associated lipocalin: comparison of the use of EDTA and heparin plasma. Clin Chem Lab Med 2012;50:1679-80.
14. ™, a fully automated neutrophil gelatinase-associated lipocalin (NGAL) immunoassay on Beckman Coulter AU 5822. Clin Chem Lab Med 2012;50:1581-4.
15. Lippi G, Sanchis-Gomar F, Sanvagno GL, Aloe R, Schena F, Guidi GC. Variation of serum and urinary neutrophil gelatinase-associated lipocalin (NGAL) after strenuous physical exercise. Clin Chem Lab Med 2012;50:1585-9.
16. Clerico A, Galli C, Fortunato A, Ronco C. Neutrophil gelatinase- associated lipocalin (NGAL) as biomarker of acute kidney disease: a review of the laboratory characteristics and clinical evidences. Clin Chem Lab Med 2012;50:1505-17.
17. Bolignano D, Donato V, Coppolino G, Campo S, Buemi A, Lacquaniti A, et al. Neutrophil gelatinase-associated lipoc-alin (NGAL) as a marker of kidney damage. Am J Kidney Dis 2008;52:595-605.
18. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005;365:1231-8.
19. Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A, NGAL Meta-analysis Investigator Group. Accuracy of neu-trophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009;54:1012-24.
20. Bolignano D, Lacquaniti A, Coppolino G, Donato V, Fazio MR, Nicocia G, et al. Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. Kidney Blood Press Res 2009;32:91-8.
21. Bolignano D, Coppolino G, Lacquaniti A, Buemi M. From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology. Eur J Clin Invest 2010;40:273-6.
22. Giaginis C, Zira A, Katsargyris A, Klonaris C, Theocharis S. Clinical implication of plasma neutrophil gelatinase-associated lipocalin (NGAL) concentrations in patients with advanced carotid atherosclerosis. Clin Chem Lab Med 2010;48:1035-41.
23. Bolignano D, Donato V, Lacquaniti A, Fazio MR, Bono C, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. Cancer Lett 2010;288:10-6.
24. Oikonomou KA, Kapsoritakis AN, Theodoridou C, Karangelis D, Germenis A, Stefanidis I, et al. Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity. J Gastroenterol Epub 2011 Dec. 27.
25. Decavele AS, Dhondt L, De Buyzere ML, Delanghe JR. Increased urinary neutrophil gelatinase associated lipocalin in urinary tract infections and leukocyturia. Clin Chem Lab Med 2011;49:999-1003.
26. Makris K, Markou N, Evodia E, Dimopoulou E, Drakopoulos I, Ntetsika K, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients. Clin Chem Lab Med 2009;47:79-82.
27. Bolignano D, Lacquaniti A, Coppolino G, Donato V, Campo S, Fazio MR, et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol 2009;4:337-44.
28. Lippi G, Salvagno GL, Banfi G. Serum but not urine concentration of neutrophil gelatinase-associated lipocalin (NGAL) is influenced by acute leukocyte variations. Leuk Lymphoma Epub 2012 Jan 20.
29. Siew ED, Ware LB, Gebretsadik T, Shintani A, Moons KG, Wickersham N, et al. Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults. J Am Soc Nephrol 2009;20:1823-32.
30. Cavalier E, Bekaert AC, Carlisi A, Legrand D, Krzesinski JM, Delanaye P. Neutrophil gelatinase-associated lipocalin (NGAL) determined in urine with the Abbott Architect or in plasma with the Biosite Triage ? The laboratory's point of view. Clin Chem Lab Med 2011;49:339-41.
31. Masuda T, Miyoshi E. Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topics. Clin Chem Lab Med 2011;49:959-66.
32. Breen DP, Michell AW, Barker RA. Parkinson's disease - the continuing search for biomarkers. Clin Chem Lab Med 2011;49:393-401.
33. Demarin V, Zavoreo I, Kes VB, Simundić AM. Biomarkers in Alzheimer's disease. Clin Chem Lab Med 2011;49:773-8.
34. van Harten AC, Kester MI, Visser PJ, Blankenstein MA, Pijnenburg YA, van der Flier WM, et al. Tau and p-tau as CSF biomarkers in dementia: a meta-analysis. Clin Chem Lab Med 2011;49:353-66
35. Mattsson N. CSF biomarkers in neurodegenerative diseases. Clin Chem Lab Med 2011;49:345-52.
36. Kwon BK, Casha S, Hurlbert RJ, Yong VW. Inflammatory and structural biomarkers in acute traumatic spinal cord injury. Clin Chem Lab Med 2011;49:425-33.
37. Sebastiani G, Gkouvatsos K, Plebani M. Non-invasive assessment of liver fibrosis: it is time for laboratory medicine. Clin Chem Lab Med 2011;49:13-32.
38. Biasucci LM, Biasillo G, Stefanelli A. Inflammatory markers, cholesterol and statins: pathophysiological role and clinical importance. Clin Chem Lab Med 2010;48:1685-91.
39. Lippi G, Favaloro EJ, Montagnana M, Franchini M. C-reactive protein and venous thromboembolism: causal or casual association? Clin Chem Lab Med 2010;48:1693-701.